Kobayashi et al. at NIH developed a therapy which results in tumor cell membrane destruction and immunogenic cell death. When activated with the ML7710 laser, there was proven efficacy against various cancer cell types including pancreatic, oral, breast, and ovarian cancer.
Modulight Spotlights: LASER-SHARP RESEARCH – January 2025 Read More »
New findings in prostate cancer research were reported by Xinning Wang and team at Case Western University, Comprehensive Cancer Center. Using ML7710 laser at 672 nm for activation of the drug, they were able to dramatically improve therapeutic effect in prostate cancer models.
Modulight Spotlights: LASER-SHARP RESEARCH – July 2024 Read More »
A promising new therapy against viruses was developed at University of Manitoba and Theralase Technologies. The study evaluated antiviral effectiveness of a cancer drug (Ruvidar), activated with Modulight’s ML6600 green laser.
Modulight Spotlights: LASER-SHARP RESEARCH – June 2024 Read More »
Many infectious agents have developed resistance to antibiotics. To combat this problem, Professor Timothy Haystead’s team at Duke University developed a novel light-based antimicrobial strategy that targets non-essential enzyme on the surface of bacteria. Light activation was done using ML7710 with 693 nm laser light to generate reactive oxygen species that successfully sterilized the bacteria.
Modulight Spotlights: LASER-SHARP RESEARCH – November 2023 Read More »
